The crystal structure of H-2D(d) MHC class I complexed with the HIV-1- derived peptide P18-110 at 2.4 Å resolution: Implications for T cell and NK cell recognition

Immunity

Volumn 9, Issue 2, 1998, Pages 199-208

  Achour, Adnane ^a   Persson, Karina ^b   Harris, Robert A ^a,b   Sundbäck, Jonas ^a   Sentman, Charles L ^c   Lindqvist, Ylva ^b   Schneides, Gunter ^b   Kärre, Klas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; CRYSTAL STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; T LYMPHOCYTE; X RAY CRYSTALLOGRAPHY;

EID: 0032143985     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80602-0     Document Type: Article

References (71)

1. Abastado, J.-P., Jaulin, C., Schutze, M.-P., Langlade-Demoyen, F., Plata, F., Ozato, K., and Kourilsky, P. (1987). Fine mapping of epitopes by intradomain recombinants. J. Exp. Med. 166, 327-340.
2. d complex: expression, refolding and crystallisation. Acta Crystallogr., in press.
3. Alexander-Miller, M.A., Parker, K.C., Tsukui, T., Pendleton, C.D., Coligan, J.E., and Berzofsky, I.A. (1996). Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-1 envelope protein to human cytotoxic T lymphocytes. Int. Immunol. 8, 641-649.
4. d with beta-2 microglobulin and peptide. Proc. Natl. Acad. Sci. USA 94, 6880-6885.
5. Bjorkman, P.J., and Parham, P. (1990). Structure, function, and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59, 253-288.
6. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L., and Wiley, D.C. (1987a). Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329, 506-512.
7. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L., and Wiley, D.C. (1987b). The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329, 512-518.
8. Bouvier, M., and Wiley, D.C. (1994). Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265, 398-402.
9. Brennan, J., Mager, D., Jefferies, W., and Takei,F. (1994). Expression of different members of the Ly-49 genefamily defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180, 2287-2295.
10. Brünger, A. (1989). Crystallographic refinement by simulated annealing: application to crambin. Acta Crystallogr. A45, 50-61.
11. Brünger, A. (1992). Free R value: a novel statistical quantity for assessing the accuracy of crystal structure. Nature 355, 472-475.
12. Cella, M., Longo, A., Ferrara, G.B., Strominger, J.L., and Colonna, M. (1994). NK3-specific natural killer cells are selectively inhibited by Bw4-positive alleles with isoleucine 80. J.Exp. Med. 180, 1235-1241.
13. Collaborative Computational Project No.4 (1994). The CCP4 suite: programs for protein crystallography. Acta Cryst. D50, 760-773.
14. Colonna, M., Borsellino, G., Falco, M., Ferrara, G.B., and Strominger, J.L. (1993a). HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1-and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90, 12000-12004.
15. Colonna, M., Brooks, E.G., Falco, M., Ferrara, G.B., and Strominger, J.L. (1993b). Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260, 1121-1124.
16. d exploits a four residue peptide binding motif. J. Exp. Med. 178, 1877-1892.
17. Correa, I., and Raulet, D.H. (1995). Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2, 61-71.
18. Daniels, B.F., Karlhofer, F.M., Seaman, W.E., and Yokoyama, W.M. (1994a). A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J. Exp. Med. 180, 687-692.
19. d, has a functional carbohydrate recognition domain. Immunity 1, 785-792.
20. Evans, S.V. (1993). SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11, 134-138.
21. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, H.G. (1991). Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.
22. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92, 2479-2483.
23. Gao, G.F., Tormo, J., Gerth, U.C., Wyer, J.R., McMichael, A.J., Stuart, D.I., Bell, J.I., Jones, E.Y., and Jakobsen, B.K. (1997). Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387, 630-634.
24. Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and Wiley, D.C. (1996). Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134-141.
25. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson, M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274, 209-219.
26. Gumperz, J.E., and Parham, P. (1995). The enigma of the natural killer cell. Nature 378, 245-248.
27. Gumperz, J.E., Litwin, V., Phillips, J.H., Lanier, L.L., and Parham, P. (1995). The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181, 1133-1144.
28. Haskins, K., Kappler, J., and Marrack, P. (1984). The major histocompatibility complex-restricted antigen receptor on T cells. Annu. Rev. Immunol. 2, 51-66.
29. Jones, Y.E. (1997). MHC class I and class II structures. Curr. Opin. Immunol. 9, 75-79.
30. Jones, T.A., Zou, J.Y., Cowan, S., and Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and location of errors in these models. Acta Crystallogr. A47, 110-119.
31. Kane, K.P. (1994). Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J. Exp. Med. 179, 1011-1015.
32. + IL-2-activated natural killer cells. Nature 358, 66-70.
33. Kärre, K. (1985). Role of target histocompatibility antigens in regulation of natural killer activity, a reevaluation and a hypothesis. In Mechanisms of Cytotoxicity by NK cells, Heberman, R.B., and Callawaert, D.M., eds. (New York: Academic Press), pp. 81-91.
34. Kärre, K., Ljunggren, H.-G., Piontek, G., and Kiessling R. (1986). Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678.
35. Korber, B., Foley, B., Leitner, T., McCutchan, F., Hahn, B., Mellors, J.W., Myers, G., and Kuiken, C. (1997). Human Retroviruses and AIDS. A Compilation and Analysis of Nucleic and Amino Acid Sequences. Theoretical Biology and Biophysics. (Los Alamos, NM: Los Alamos National Lab).
36. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structure. J. Appl. Cryst. 24, 946-950.
37. Laskowski, R.J., Macarthur, W., Moss, D., and Thornton, J. (1993). Procheck: a program to check stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-290.
38. Litwin, V., Gumperz, J.E., Parham, P., Philips, J.H., and Lanier, L.L. (1994). NKB1 : a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180, 537-543.
39. Ljunggren, H.G., and Kärre, K. (1990). In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
40. Long, E.O., Burshtyn, D.N., Clark, W.P., Peruzzi, M., Rajagopalan, S., Rojo, S., Wagtmann, N., and Winter, C.C. (1997). Killer cell inhibitory receptors: diversity, specificity, and function. Immunol. Rev. 155, 135-144.
41. Lu, G. (1996). A www service system for automatic comparison of protein structures. Protein Data Bank Quarterly Newsletter 78, 10-11.
42. Luque, I., Solana, R., Galiani, M.D., Gonzalez, R., Garcia, F., Lopez de Castro, J.A., and Pena, J. (1996). Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones. Eur. J. Immunol. 26, 1974-1977.
43. MacArthur, M.W., and Thornton, J.M. (1991). Influence of proline residues on protein conformation. J. Mol. Biol. 218, 397-412.
44. Madden, D.R. (1995). The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13, 587-622.
45. Matsumoto, N., Ribaudo, R.K., Abastado, J.-P., Margulies, D.H., and Yokoyama, W.M. (1998). The lectin-like NK cell receptor Ly-49A recognizes a carbohydrate-independent epitope on its MHC class I ligand. Immunity 8, 245-254.
46. Moretta, A., Vitale, M., Bottino, C., Orengo, A.M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E., and Moretta, L. (1993). p58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti p58 antibodies reconstitute lysis of MHC class I protected cells in NK clones displaying different specificities. J. Exp. Med. 178, 597-604.
47. Murshudov, G.N., Vagin, A.A., and Dodson, E.J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D53, 240-255.
48. Navaza, J. (1994). AMoRe: an automated package for molecular replacement. Acta Cryst. A50, 157-163.
49. Nicholls, A., Sharp, K.A., and Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
50. Orihuela, M., Margulies, D.H., and Yokoyama, W.M. (1996). The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc. Natl. Acad. Sci. USA 93, 11792-11797.
51. Otwinowski, Z. (1993). Oscillation data reduction program. In Data Collection and Processing, L. Sawyer, N. Issacs, and S. Bailey, eds. (Warrington, United Kingdom: Daresbury Laboratory), pp. 55-62.
52. Rammensee, H.-G., Friede, T., and Stevanovic, S. (1995). MHC ligands and their peptide motifs: first listing. Immunogenetics 41, 178-228.
53. Ryan, J.C., and Seaman, W.E. (1997). Divergent functions of lectin-like receptors on NK cells. Immunol. Rev. 155, 79-89.
54. 2 domains. J. Immunol. 153, 5482-5490.
55. Shirai, M., Pendleton, C.D., and Berzofsky, J.A. (1992). Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J. Immunol. 148, 1657-1667.
56. Shirai, M., Vacchio, M.S., Hodes, R.J., and Berzofsky, J.A. (1993). Preferential Vβ usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp 160 and degenerate in class I MHC restriction. J. Immunol. 151, 2283-2295.
57. Shirai, M., Kurokohchi, K., Pendleton, C.D., Arichi, T., Boyd, L.F., Takahashi, H., Margulies, D.H., and Berzofsky, J.A. (1996). Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp 160. J. Immunol. 157, 4399-4411.
58. Shirai, M., Kozlowski, S., Margulies, D.H., and Berzofsky, J.A. (1997). Degenerate M HC restriction reveals the contribution of class I molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160V3 loop. J. Immunol. 158, 3181-3188.
59. d restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A. J. Immunol. 160, 5971-5978.
60. Takahashi, H., Houghten, R., Putney, S.D., Margulies, D.H., Moss, B., Germain, R.N., and Berzofsky, J.A. (1989a). Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. J. Exp. Med. 170, 2023-2035.
61. Takahashi, H., Merli, S., Putney, S.D., Houghten, R., Moss, B., Germain, R.N., and Berzofsky, J.A. (1989b). A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science 246, 118-121.
62. Takahashi, H., Nakagawa, Y., Pendleton, C.D., Houghten, R., Yokomuro, K., Germain, R.N., and Berzofsky, J.A. (1992). Induction of broadly cross-reactive cytotoxic cells recognizing an HIV-1 envelope determinant. Science 255, 333-336.
63. Takei, F., Brennan, J., and Mager, D.L. (1997). The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol. Rev. 755, 67-77.
64. Takeshita, T., Takahashi, H., Kozlowski, S., Ahlers, J.D., Pendleton, C.D., Moore, R.L., Nakagawa, Y., Yokomuro, K., Fox, B.S., Margulies, D.H., et al. (1995). Molecular analysis of the same HIV peptide binding to both a class I and aclass II MHC molecule. J. Immunol. 154, 1973-1986.
65. Townsend, A.R., Rothbard, J., Gotch, F.M., Bahadur, G., Wraith, D., and McMichael, A.J. (1986). The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. J. Exp. Med., 44, 959-968.
66. + NK cells after amino acid substitutions in the antigen binding cleft. Eur. J. Immunol., in press.
67. Watts, S., Wheeler, C., Morse, R., and Goodenow, R.S. (1989). Amino acid comparison of the class I antigens of mouse major histocompatibility complex. Immunogenetics 30, 390-392.
68. Wilmot, C.M., and Thornton, J.M. (1990). β-turns and their distortions: a proposed new nomenclature. Prot. Eng. 3, 479-493.
69. b at 2.4Å resolution: Implications for antigen-determinant selection. Cell 76, 39-50.
70. Young, A.C., Nathenson, S.G., and Sacchettini, J.C. (1995). Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation. FASEB J. 9, 26-36.
71. Zinkernagel, R.M., and Doherty, P.C. (1974). Restriction of in vitro T cell-mediated cytotoxicity in lymphotic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701-702.